Anthropic and OpenAI IPO: how Indian residents can buy in, and which RSU holders are already winning

The two most consequential private technology companies in the world right now are not in the same industry as Uber or Airbnb or WeWork were when those companies dominated the pre-IPO conversation. Anthropic and OpenAI are building what may turn out to be the general-purpose computing layer of the next decade. Their investors and strategic partners include the most valuable public companies on earth — Microsoft, Google, Amazon, Oracle, Salesforce — and if either company goes public, the IPO will likely be the largest tech listing since Facebook in 2012 and among the most anticipated market events of the decade.

For Indian retail investors, the question is: how do you participate?

The honest version of that answer is layered: you cannot buy either company's shares today (they are private). You can buy public proxies today. And you can prepare for the LRS-funded purchase the moment either company lists. Meanwhile, if you're an RSU holder at any of the major strategic partners — Microsoft, Oracle, Salesforce, Amazon, Google — you're already sitting on embedded upside from these companies' growth, whether or not the IPOs happen.

This article covers all four angles: the IPO timeline reality, the public proxies available today, the LRS mechanics for when they list, and the RSU-holder angle that most articles on this topic ignore entirely.

The two companies: what they are and what they're worth

OpenAI is the company behind GPT-4, GPT-4o, o3, and ChatGPT — the product that reached 100 million users faster than any in history and forced a decade of AI safety research into a two-year commercial sprint. OpenAI's reported private valuation in its October 2024 fundraising round was $157 billion, making it briefly the third-most-valuable private company in the world behind SpaceX and ByteDance. More recent secondary transactions and reports suggest the implied valuation has continued to climb — some analyst estimates for a public listing scenario range from $200–300 billion, driven by ChatGPT's subscriber growth, the Enterprise API business, and the emerging reasoning model franchise (o3, o4).

OpenAI's funding base includes Microsoft (~$13 billion invested over multiple rounds, giving Microsoft a reported ~49% of OpenAI's profits up to a cap), SoftBank ($6.6 billion in the 2024 round, with additional Stargate commitments), Thrive Capital, Khosla Ventures, and Tiger Global. Oracle has a significant infrastructure partnership — it is one of the three Stargate consortium members alongside OpenAI and SoftBank, with Oracle committing to build out the AI data centre infrastructure OpenAI needs to train and serve its models.

Anthropic is OpenAI's most technically credible competitor, founded in 2021 by Dario Amodei, Daniela Amodei, and several core OpenAI researchers including the lead author of the GPT-2 and GPT-3 training work. Anthropic builds the Claude family of models (Claude 3, Claude 3.5, Claude 4, and subsequent generations) and positions itself on safety-first AI development. Anthropic's most recent funding round in early 2026 valued the company at approximately $61 billion. Major investors include Amazon (up to $4 billion committed, with AWS as the primary cloud partner), Google (approximately $2 billion), Salesforce Ventures, Spark Capital, and General Catalyst. The June 2026 Apollo-Anthropic structured debt deal — in which Apollo Global Management extended a $1.5 billion credit facility — was notable as a signal that private credit markets, not just venture capital, are now underwriting frontier AI infrastructure.

Company	Latest private valuation	Key investors	Revenue trajectory
OpenAI	~$200–300B (implied)	Microsoft, SoftBank, Oracle (infra), Thrive	$3–4B ARR reported 2024; $11.6B projected 2025
Anthropic	~$61B (early 2026)	Amazon, Google, Salesforce Ventures	$1–2B ARR, enterprise acceleration

Will either company actually IPO? The honest timeline

The question Indian investors keep asking — "when is the OpenAI IPO?" — deserves an honest answer rather than a headline-chasing one.

OpenAI: Sam Altman has discussed a public offering in various interviews, and the October 2024 restructuring from a "capped-profit" LLC to a Delaware public benefit corporation was widely interpreted as IPO preparation. The PBC structure is what you convert to before going public. Altman has been quoted suggesting a potential 2025 or 2026 window. However, OpenAI's corporate restructuring is complex — the non-profit board still has a governance role, the Microsoft profit-cap mechanics need to be resolved, and the company has been burning cash at a rate that would put enormous scrutiny on any S-1. The most plausible scenario: a 2026–2027 IPO window, likely after the current AI spending cycle either validates or corrects. If the AI CapEx cycle remains intact and OpenAI's Enterprise revenue meets projections, the IPO conditions are there. If the AI spending narrative cracks — if hyperscalers reduce CapEx guidance — OpenAI may stay private longer.

Anthropic: Dario Amodei has been more guarded on timeline. Anthropic has raised enough private capital (and now private credit from Apollo) to run for years without a public listing. The Amazon and Google strategic investments mean Anthropic has distribution — AWS and Google Cloud are both selling Claude API access — which reduces the need for a public listing to raise brand awareness. The most plausible scenario: Anthropic lists after OpenAI, potentially 2027–2028, using the precedent to price more favourably. If the AI consolidation thesis plays out — where 2–3 frontier labs survive and the rest fade — Anthropic's IPO would be a generational bet on which one of those survivors it is.

Neither IPO is confirmed. Neither has a filing date. This article is written when both companies remain private. Treat any "IPO date" headline with the same scepticism the SpaceX IPO headlines have deserved for five years.

But here's what is different about AI: the revenue curves are real and current, not speculative like SpaceX's Mars or Starlink subscriber forecasts. OpenAI had approximately $3.7 billion in annualised revenue in late 2024 and is growing fast. The companies are not pre-revenue bets; they are high-burn, fast-growing revenue businesses. That makes the IPO timing a financial engineering question, not a viability question.

How Indian residents can buy Anthropic or OpenAI shares when they IPO

When either company lists on a US exchange (NASDAQ or NYSE, almost certainly), Indian residents can buy shares through the Liberalised Remittance Scheme (LRS) — the same mechanism used to buy Apple, NVIDIA, or any other US-listed stock today. The process:

1. Remit USD via your Indian bank to your US brokerage account (Vested, Rovia, IndMoney, IBKR, or any other LRS-eligible platform). The annual cap is $250,000 per individual.
2. TCS at source: Your bank deducts 20% TCS (Tax Collected at Source) on the LRS remittance above ₹10 lakh in the financial year. This is not a tax — it is an advance you recover via ITR filing. The TCS credit appears in Form 26AS and is set off against your total tax liability for the year.
3. Place the IPO order via your US brokerage on listing day. Most IPO shares are allocated only to institutional investors on Day 1 — retail investors typically buy in the secondary market once trading opens. Do not confuse being able to buy on Day 1 as equivalent to getting the IPO price; if the stock opens at 2× the IPO price (as many high-profile tech IPOs do), retail buyers pay the opened price, not the IPO price.
4. Avoid overloading a single LRS window. A ₹10 lakh+ remittance triggers the 20% TCS withholding. If you plan to invest ₹20–30 lakh in either IPO, consider spreading the remittance across the financial year — remit ₹10 lakh in March (FY 2026-27) and the balance in April (FY 2027-28) — to manage TCS cash flow even though you recover it.
5. GIFT City / NSE-IX route: If either company lists its shares or DRs on the NSE International Exchange (NSE-IX) in GIFT City, Indian residents could potentially buy without the LRS/TCS mechanics and with different tax treatment (10% flat capital gains under IFSC rules). This is speculative — neither company has announced any GIFT City listing. But watch for it as Indian regulators continue to expand the GIFT City stock universe.

Step	What it means for you
LRS remittance	Wire USD to US broker; ₹10 lakh+ triggers 20% TCS (refundable via ITR)
Brokerage account	Rovia, Vested, IBKR — any LRS-eligible US broker
Day 1 vs IPO price	Retail buyers pay market price on listing day, not the IPO allocation price
Tax at vest/buy	No perquisite tax for market purchases — capital gains only
Schedule FA	Disclose US brokerage holding every January 1–December 31
LTCG clock	24 months from purchase date; 12.5% at LTCG vs slab at STCG

One warning specific to high-profile AI IPOs: post-IPO lock-up expiry has historically caused sharp corrections in high-profile tech listings as insider shareholders begin selling. ARM Holdings (September 2023 IPO at $51, 180-day lockup expiry in March 2024) saw the stock peak at $164 before normalising. Retail investors who chased the day-1 opening print at $65–70 and held through the lockup expiry and normalisation saw significant drawdown. The rational approach for IPO participation: buy in tranches, not a lump sum on Day 1.

Public-market proxies you can buy today

Since neither company is public, the next-best option is buying the companies already listed that have significant financial exposure to OpenAI or Anthropic's success.

Microsoft (MSFT) — the OpenAI insider

Microsoft's investment in OpenAI is not a passive minority stake. It is a structural partnership: Microsoft has committed approximately $13 billion over multiple rounds and holds a reported ~49% of OpenAI's profits up to a capped amount. Azure OpenAI Service is one of Microsoft's fastest-growing cloud products. GitHub Copilot — Microsoft's AI coding assistant built on OpenAI's models — had over 1.3 million paid subscribers as of 2024 and is growing.

Microsoft's total market capitalisation is approximately $3 trillion. The OpenAI investment and associated Azure revenue could represent $200–300 billion of incremental value on an upside scenario — roughly 7–10% of Microsoft's current market cap, but concentrated in one of the fastest-growing product lines. For Indian RSU holders at Microsoft: the Azure OpenAI revenue acceleration directly supports the revenue and operating income lines that determine MSFT's valuation and, by extension, your RSU vest value. A successful OpenAI IPO that crystallises value would likely create a MSFT re-rating event.

Oracle (ORCL) — the infrastructure backbone of Stargate

Oracle's position in the AI infrastructure bet is underappreciated. Oracle is one of three Stargate consortium members (along with OpenAI and SoftBank), committed to building the data centre infrastructure OpenAI needs to train and serve its next generation of models. In February 2025, Stargate's $500 billion AI infrastructure plan was announced with Oracle's Larry Ellison standing beside Sam Altman and SoftBank's Masayoshi Son in the White House. Oracle Cloud Infrastructure (OCI) is now a primary provider for OpenAI's compute — a relationship worth tens of billions in revenue if the Stargate build-out proceeds.

Oracle's stock has re-rated significantly on the AI infrastructure narrative — from approximately $100 in early 2023 to $160–200 through 2024–2026. For Indian RSU holders at Oracle: your unvested equity already has embedded OpenAI infrastructure upside. The risk is whether Stargate's build-out proceeds on the announced timeline and at the announced capital levels, or whether any slowdown in AI spending growth pressures both Oracle Cloud bookings and the Stargate narrative simultaneously.

Salesforce (CRM) — the Anthropic enterprise bet

Salesforce Ventures invested in Anthropic's funding rounds, and Salesforce has integrated Claude into its Agentforce platform — the AI agent product it launched as its core growth driver in FY2025. Agentforce essentially bets that enterprise AI workflows will run on Salesforce's platform with Anthropic's Claude as the reasoning engine. This is both a strategic investment and a product architecture decision.

Salesforce's stock trajectory is linked to Agentforce adoption, which is linked to Claude's enterprise performance, which is linked to Anthropic's model quality and pricing. For Indian RSU holders at Salesforce: the Agentforce bet is a concentrated AI-era revenue bet, and Anthropic's success as a company directly supports the product architecture Salesforce is staking its next growth phase on.

Amazon (AMZN) — Anthropic's largest external investor

Amazon committed up to $4 billion in Anthropic — the largest single external investment in the company — with AWS as Anthropic's primary cloud provider. In exchange, Anthropic models are available via AWS Bedrock, and Amazon's Alexa and internal teams use Claude for AI capabilities. The Amazon-Anthropic relationship is the closest structural parallel to the Microsoft-OpenAI relationship on the Anthropic side: a hyperscaler with both financial exposure and cloud distribution.

Amazon's stock already reflects AWS's AI momentum. An Anthropic IPO at a $100B+ valuation would crystallise value on Amazon's balance sheet — the $4B investment on an Anthropic valuation of $61B implies Amazon holds roughly 6–7% of Anthropic at cost; at a $150B IPO valuation, that position would be worth approximately $9–10B on paper. For Indian RSU holders at Amazon: your vested AMZN shares already carry embedded Anthropic upside, and your unvested equity benefits from AWS cloud revenue that the Anthropic partnership directly generates.

Google/Alphabet (GOOGL) — the complicated hedge

Google invested approximately $2 billion in Anthropic while simultaneously running its own frontier AI lab (Google DeepMind) that produces Gemini — Anthropic's direct competitor. This is not a contradiction: Google's Anthropic investment is simultaneously a strategic hedge against OpenAI, a way to ensure Anthropic builds on Google Cloud (TPUs), and a financial investment. Google Cloud is Anthropic's second major cloud provider after AWS.

Google is in the most complex position of any strategic partner: it competes with Anthropic's Claude directly (Gemini vs Claude), invests in Anthropic, and sells Anthropic's models via Google Cloud Vertex AI. For Indian RSU holders at Google: your equity has Anthropic upside through Google's investment, Gemini upside through Google's own AI development, and risk of disruption if either Claude or ChatGPT structurally takes enterprise AI share from Gemini.

NVIDIA (NVDA) — the infrastructure layer below everyone

NVIDIA is not an investor in either OpenAI or Anthropic, but it is the infrastructure layer on which both companies run. Training GPT-4, Claude 3, and every subsequent frontier model has required enormous NVIDIA GPU clusters — H100s, then H200s, then Blackwell B100s. OpenAI and Anthropic are among the largest buyers of NVIDIA compute in the world, and the Stargate build-out that Oracle is constructing for OpenAI is NVIDIA-GPU-based data centre infrastructure.

An OpenAI IPO that triggers a wave of AI infrastructure investment across hyperscalers and enterprises is a direct NVIDIA revenue catalyst. NVIDIA's stock has already reflected much of the AI infrastructure boom — trading at >30x forward revenue at various points in 2024 — but every confirmation of sustained enterprise AI adoption supports NVIDIA's data centre revenue trajectory. For Indian RSU holders at NVIDIA: you are already the most direct beneficiary of the AI infrastructure cycle. An OpenAI IPO is a confirmation event for the thesis your equity is priced on.

Summary: public proxies ranked by directness of exposure

Company	Exposure type	Directness	Listed on	Indian investor route
Microsoft	~49% OpenAI profit cap; Azure OpenAI products	Very high	NASDAQ	LRS → any US broker
Oracle	Stargate Consortium; OCI compute for OpenAI	High	NYSE	LRS → any US broker
Amazon	Up to $4B invested in Anthropic; AWS Bedrock	High	NASDAQ	LRS → any US broker
Salesforce	Salesforce Ventures in Anthropic; Agentforce on Claude	Medium-high	NYSE	LRS → any US broker
Google	~$2B invested in Anthropic; Google Cloud	Medium	NASDAQ	LRS → any US broker
NVIDIA	Compute infrastructure for both; indirect	Medium	NASDAQ	LRS → any US broker
SoftBank	OpenAI investor; Stargate funder	Medium	TSE (Tokyo)	Harder LRS route

Which RSU holders are already sitting on embedded upside

If you work at any of the companies above, your unvested RSUs already carry embedded exposure to the AI race — and specifically to OpenAI or Anthropic's growth. Here's what that means in practice for each group:

Microsoft RSU holders: Every quarterly vest puts MSFT shares in your account. Microsoft's revenue and earnings — and therefore its stock price — are increasingly tied to Azure AI services built on OpenAI. The Azure OpenAI Service, GitHub Copilot, Microsoft 365 Copilot, and Bing Chat represent a product line that barely existed in 2022 and is now a material growth driver. Your unvested RSU value is partly a bet that OpenAI's models continue to drive Azure differentiation. An OpenAI IPO crystallising the value of Microsoft's stake — even partially, through analyst re-rating — would be a tailwind for MSFT.

Oracle RSU holders: Oracle's stock re-rating from a $100 "legacy enterprise" stock to a $160–200 "AI infrastructure" stock has already happened. Much of that re-rating was Stargate. The question now is whether Stargate's capital commitments translate into actual Oracle Cloud bookings over the next 3–5 years at the scale implied by the $500 billion announcement. If they do, your unvested Oracle equity benefits. If Stargate spending is slower than announced — or if OpenAI's compute needs are met through AWS and Azure rather than OCI — the Oracle stock story weakens.

Salesforce RSU holders: Agentforce is Salesforce's biggest growth bet in a decade. It is built on Claude. If Anthropic's models maintain quality and cost leadership vs OpenAI and Google, Agentforce wins. If Claude loses ground to GPT-5 or Gemini Ultra in enterprise tasks, Salesforce has a product architecture problem. Your RSU value at Salesforce is increasingly a concentrated bet on the Claude-Agentforce combination working.

Amazon RSU holders: AWS is the cloud backbone for both AI training (via NVIDIA GPU clusters available on AWS) and AI inference (via AWS Bedrock, which serves Claude, Llama, Titan, and other models). Amazon's $4B investment in Anthropic reinforces AWS's position as the enterprise AI API provider of choice for companies that don't want Microsoft or Google infrastructure. Every dollar of Anthropic revenue that flows through AWS Bedrock is an Amazon revenue event. Your unvested AMZN equity benefits from both Anthropic's growth (investment appreciation on balance sheet) and the AWS cloud revenue it drives.

Google RSU holders: Google's position is the most complex because it is simultaneously a beneficiary (Anthropic investment, Google Cloud distribution) and a competitive threat target (Gemini vs Claude, Google Search vs ChatGPT). Your GOOGL equity benefits if Google's AI investments — both Anthropic and DeepMind's Gemini — maintain enterprise adoption and if Google Cloud takes share in the AI workload market. It is pressured if ChatGPT continues to displace Google Search for query-answer use cases and if Claude displaces Gemini in the enterprise AI market that Google Cloud is trying to win.

NVIDIA RSU holders: NVIDIA is the clearest single-stock expression of the AI infrastructure build-out. An OpenAI IPO that validates AI spending at scale, an Anthropic Series E at $100B+ that funds massive compute orders, or any signal of continued hyperscaler GPU demand is a direct positive for your NVDA vest value. The concentration risk for NVIDIA RSU holders is that your salary, bonus, and unvested equity all depend on the same AI CapEx cycle. A macro slowdown that causes hyperscalers to reduce data centre spending would pressure NVDA's stock, your compensation growth, and your unvested equity simultaneously.

What RSU holders should do — and why concentration makes this urgent

If you hold RSUs at any of these companies — Microsoft, Oracle, Salesforce, Amazon, Google, NVIDIA — you face a structural problem that goes beyond ordinary RSU concentration risk. You are already highly concentrated in the AI trade, whether you chose to be or not.

At vest, the standard question is: "If I received this as cash, would I immediately use it to buy more of my employer's stock?" For most people, the honest answer is no. The AI narrative has driven valuations across the board — NVIDIA is trading at historically premium multiples, Microsoft has re-rated, Oracle has re-rated, Salesforce has re-rated — and these valuations embed significant expectations about AI revenue growth materialising over the next 3–7 years. If that growth materialises, those stocks will hold their value or appreciate. If the AI spending cycle corrects — if enterprise AI ROI proves harder to demonstrate, if hyperscaler CapEx guidance cuts cause a sentiment reversal, or if a frontier model disappointment (a GPT-5 that underdelivers, a Claude 4 safety failure) triggers a sector de-rating — then the stocks you're accumulating via RSU vests will drop at the same time your employer faces salary pressure, hiring freezes, and benefit cuts.

The standard financial planning guidance applies with extra force here: treat each RSU vest as a cash payment event. Sell at vest, diversify, and redeploy into assets that don't move in lockstep with your employer's stock.

What does redeployment look like?

• Broad US index: VOO (Vanguard S&P 500 ETF) or VTI (Vanguard Total US Market) gives you exposure to the entire US market, including NVIDIA, Microsoft, and every other AI beneficiary, in proportion to their market-cap weight — but also diluted by the other 490–3,000 companies in the index that aren't correlated to your employer's AI story.
• Ireland-domiciled UCITS ETFs: If you're concerned about US estate tax (US-situs assets above $60,000 are subject to 40% US estate tax for NRAs), use CSPX (iShares S&P 500 UCITS ETF, listed on LSE) or VWRA (Vanguard FTSE All World UCITS) via Rovia or IBKR. UCITS ETFs are not US-situs assets — no US estate tax exposure.
• Indian equity: Diversify some proceeds back to India, via an Indian equity index fund or multi-asset fund, to reduce the USD/INR currency concentration.

The Rovia mechanic for RSU holders specifically: Rovia offers a direct ACATS transfer from your employer's equity platform (Fidelity NetBenefits, E*TRADE/Morgan Stanley at Work, Shareworks) to your Rovia account — no capital gains event on the transfer, cost basis and vest dates transfer in-kind. Once in Rovia, you can sell at 0.15% brokerage (among the lowest for India-facing US brokers), see your STCG/LTCG position pre-computed in INR, and repatriate proceeds to your Indian bank account. The workflow: vest in employer platform → ACATS transfer to Rovia → sell → reinvest in VTI/CSPX or repatriate to India.

If you're an Oracle employee holding a large ORCL position built up through multiple annual RSU grants, a Salesforce employee with CRM accumulated over 4–5 years of quarterly vests, or an Amazon employee sitting on AMZN shares from cliff vests at low 2022 prices — the question is not whether your AI narrative thesis is right. It is whether you want your entire financial life to depend on whether it is. Salary: yes, depends on your employer. Bonus: yes, depends on your employer. Unvested future RSUs: yes, depends on your employer. Vested accumulated holdings that you haven't sold: this is the only variable you control. That's the variable worth optimising.

See the RSU diversification playbook and should you sell at vest or hold for the full framework.

The LTCG angle: timing your proxy sales before the IPO

If you bought any of the public AI proxies — MSFT, ORCL, AMZN, CRM, GOOGL, NVDA — through your Rovia or other brokerage account more than 24 months ago, those positions are eligible for the 12.5% LTCG rate (plus 4% cess = 13%) under Section 112, rather than your slab rate (30% + surcharge + cess = up to 35.88% for highest-income earners).

The difference is significant. On a ₹10 lakh gain: LTCG at 12.5% = ₹1,25,000 tax. STCG at 30% = ₹3,00,000 tax. A difference of ₹1,75,000 in tax on the same gain.

If you're holding a public AI proxy position and an OpenAI or Anthropic IPO event is on the horizon, it is worth tracking whether any of your lots cross the 24-month threshold in the months ahead. The rational sequence: hold the lot until LTCG-eligible, then evaluate whether to sell the proxy and reinvest directly into the IPO when it lists — swapping an indirect proxy for direct exposure at lower long-term capital gains cost.

Practical LTCG tracking in Rovia: Rovia's India-facing interface pre-computes STCG vs LTCG status for each of your lots in INR. You can see exactly which lots are within the 24-month window and which have crossed it, without needing a spreadsheet. This is one of the specific reasons RSU holders transferring to Rovia find the platform worth using — the Indian tax overlay is built in rather than bolted on.

What to watch for as IPO signals

Indian investors waiting for either IPO can monitor the following signals:

OpenAI:

• S-1 filing on SEC EDGAR — the public filing that precedes a US IPO by 3–6 months. Search EDGAR (efts.sec.gov) for "OpenAI" or "OAI Corp". Currently no filing.
• Corporate structure completion — OpenAI's conversion to a Delaware PBC needs to be completed and the non-profit board's governance role needs to be resolved. Watch for press releases from OpenAI on its corporate restructuring status.
• Microsoft profit cap resolution — the capped-profit mechanics of the original deal need to be converted to something that works in a public-company context. Announcements of this resolution would be a strong IPO signal.
• Revenue milestones — OpenAI projected ~$11.6B in 2025 revenue. If actual 2025 revenue hits or exceeds this, it strengthens the IPO case. If it misses materially, the IPO may be delayed.

Anthropic:

• S-1 filing on SEC EDGAR — same mechanism.
• Amazon and Google stake clarifications — both Amazon and Google have strategic relationships that would need to be disclosed and may have specific terms around a public offering.
• Apollo credit facility terms — the June 2026 Apollo deal included terms that may include covenants relevant to a future IPO. Watch for any refinancing or modification of this facility as a signal.
• Claude API revenue — Anthropic's enterprise API business drives its valuation case. Announcements about Claude API growth milestones (crossing 1M developers, Enterprise customer count disclosures) are signals of IPO-readiness.

Bottom line

Anthropic and OpenAI are the two most valuable private AI companies in the world, and an IPO from either — particularly OpenAI — would be among the most significant market events of the decade. Indian retail investors can participate when they list via the standard LRS route: remit USD, buy via Rovia or any other LRS-eligible US broker, declare the holding in Schedule FA, and track LTCG windows from the purchase date.

While you wait, the public-market proxies — Microsoft, Oracle, Amazon, Salesforce, Google, NVIDIA — already embed meaningful exposure to both companies' success. And if you're an RSU holder at any of those companies, you already have more AI concentration than most investors: your salary, bonus, and unvested equity all depend on the same narrative. The rational response is to sell RSU vests as they land, redeploy into diversified index ETFs via Rovia, and keep your direct AI exposure through the diversified index rather than through employer concentration. If either company IPOs and you want to add direct exposure, you can do that on top of a diversified base — rather than on top of already-concentrated employer equity.

The Rovia platform is the specific mechanism that makes this practical: ACATS transfer from your employer's equity platform, 0.15% brokerage, INR-view of your STCG/LTCG position, and direct repatriation to your Indian bank. The diversification playbook is the same regardless of which AI company lists first.

---

This article is general information, not personalised investment, tax, or legal advice. Valuations cited are based on reported information as of August 2026 and are subject to change. Neither Anthropic nor OpenAI has filed or confirmed a public offering. Verify current facts and consult a qualified advisor before making investment decisions.